EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte Studie

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

Troels Yndigegn, Bertil Lindahl, Katarina Mars, Joakim Alfredsson, Jocelyne Benatar, Lisa Brandin, David Erlinge, Ola Hallen, Claes Held, Patrik Hjalmarsson, Pelle Johansson, Patric Karlström und 8 weitere

New England Journal of Medicine · 18.04.2024 · 390 (15) · 1372-1381

DOI: 10.1056/nejmoa2401479 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift New England Journal of Medicine, erschienen am 18.04.2024. Verfasst von Troels Yndigegn und 19 weiteren Autor:innen. Beteiligte Einrichtung: From the Department of Cardiology, Clinical Sciences, Lund University, and Skåne University Hospital, Lund (T.Y., D.E.), the Department of Medical Sc…. Hauptthemen laut MEDLINE: Adrenergic beta-Antagonists, Bisoprolol, Myocardial Infarction, Metoprolol. Die Arbeit wurde bisher 326-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Stockholm läns landsting, Hjärt-Lungfonden, Eesti Teadusagentuur.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adrenergic beta-AntagonistsBisoprololMyocardial InfarctionMetoprololHumansHeart FailureStroke VolumeTreatment OutcomeVentricular Function, LeftSecondary Prevention

Substanzen

Adrenergic beta-AntagonistsBisoprololMetoprolol

Autor:innen und Institutionen

  • From the Department of Cardiology, Clinical Sciences, Lund University, and Skåne University Hospital, Lund (T.Y., D.E.), the Department of Medical Sciences, Uppsala University (B.L., C.H., J.S.), and Uppsala Clinical Re…

ORCID-Profile: Robin Hofmann

Förderung

  • Stockholm läns landsting
  • Hjärt-Lungfonden
  • Eesti Teadusagentuur
  • Vetenskapsrådet
  • Greenlane research and educational fund

Zitieren

APA

Yndigegn, T., Lindahl, B., Mars, K., Alfredsson, J., Benatar, J., Brandin, L., Erlinge, D., Hallen, O., Held, C., Hjalmarsson, P., Johansson, P., Karlström, P., Kellerth, T., Marandi, T., Ravn-Fischer, A., Sundström, J., Östlund, O., Hofmann, R., Jernberg, T., & REDUCE-AMI Investigators (2024). Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. New England Journal of Medicine, 390(15), 1372-1381. https://doi.org/10.1056/nejmoa2401479

Vancouver

Yndigegn T, Lindahl B, Mars K, Alfredsson J, Benatar J, Brandin L, et al. Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction. New England Journal of Medicine. 2024;390(15):1372-1381. doi:10.1056/nejmoa2401479

BibTeX
@article{Yndigegn2024,
  author = {Yndigegn, Troels and Lindahl, Bertil and Mars, Katarina and Alfredsson, Joakim and Benatar, Jocelyne and Brandin, Lisa and Erlinge, David and Hallen, Ola and Held, Claes and Hjalmarsson, Patrik and Johansson, Pelle and Karlström, Patric and Kellerth, Thomas and Marandi, Toomas and Ravn-Fischer, Annica and Sundström, Johan and Östlund, Ollie and Hofmann, Robin and Jernberg, Tomas and REDUCE-AMI Investigators, REDUCE-AMI Investigators},
  title = {Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction},
  journal = {New England Journal of Medicine},
  year = {2024},
  volume = {390},
  number = {15},
  pages = {1372--1381},
  doi = {10.1056/nejmoa2401479}
}
Kostenlos starten →